Market Overview

Mid-Morning Market Update: Markets Mostly Lower; JPMorgan Tops Q2 Views


Following the market opening Tuesday, the Dow traded up 0.15% to 26123.80 while the NASDAQ fell 1.74% to 10210.48. The S&P also fell, dropping 0.55% to 3,137.81.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 3,364,547 cases with around 135,615 deaths. Brazil confirmed a total of over 1,884,967 COVID-19 cases with 72,833 deaths, while India reported a total of at least 906,752 confirmed cases and 23,727 deaths. In total, there were at least 13,113,181 cases of COVID-19 worldwide with over 573,288 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Energy shares rose 1.5% on Tuesday.

In trading on Tuesday, consumer discretionary shares fell 1.8%.

Top Headline

JPMorgan Chase & Co. (NYSE: JPM) reported better-than-expected results for its second quarter.

JPMorgan reported quarterly earnings of $1.38 per share, beating analysts’ estimates of $1.04 per share. The company reported sales of $33.00 billion, exceeding expectations of $30.29 billion.

Equities Trading UP

INmune Bio, Inc. (NASDAQ: INMB) shares shot up 85% to $16.40 following a positive clinical readout from the company. The company released interim results from a Phase 1b study of its lead drug candidate XPro 1595 in Alzheimer's disease, showing the investigational drug reduced neuroinflammation by 40.6% in a brain fiber pathway, which is important for learning and memory.

Shares of Rigel Pharmaceuticals, Inc (NASDAQ: RIGL) got a boost, shooting 83% to $3.955 after the company announced the launch of an investigator-sponsored trial of Fostamatinib for the treatment of COVID-19 pneumonia.

Perceptron, Inc. (NASDAQ: PRCP) shares were also up, gaining 67% to $5.25 after the company received an order from an automotive supplier for its in-line measurement technology.

Equities Trading DOWN

Equillium, Inc. (NASDAQ: EQ) shares tumbled 38% to $16.50 after the company filed a prospectus supplement related to a common stock offering of up to $150 million. Equillium shares jumped more than 730% on Monday after the company announced its clinical trial showed Itolizumab reduced mortality in patients hospitalized with COVID-19.

Shares of WiMi Hologram Cloud Inc. (NASDAQ: WIMI) were down 31% to $16.99. WiMi Hologram Cloud shares jumped 69% on Monday on continued momentum after the company announced its AR+AI Vision will drive a new wave of 5G applications.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) was down, falling 19% to $41.55 after surging 23% on Monday.


In commodity news, oil traded down 0.6% to $39.85, while gold traded down 1.1% to $1,794.20.

Silver traded down 2.6% Tuesday to $19.28, while copper fell 1% to $2.9265.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 1.3%, the Spanish Ibex Index fell 1.2%, while Italy’s FTSE MIB Index declined 1%. Meanwhile, the German DAX 30 dropped 1.5%, French CAC 40 declined 1.7% and UK shares fell 0.3%.


The NFIB small business optimism index rose to 100.6 in June, a 6.2 points rise from May's reading.

US inflation rate rose to 0.6% in June versus May's 0.1%.

The Treasury is set to auction 52-week bills at 11:30 a.m. ET.

Federal Reserve Governor Lael Brainardis set to speak at 2:00 p.m. ET.

Federal Reserve Bank of St. Louis President James Bullard will speak at 2:30 p.m. ET.


Related Articles (EQ + INMB)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Global Intraday Update Markets